Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

Todd Neale

December 05, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Daily News

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Yael L. Maxwell

May 02, 2016

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Does the Watchman LAA Occluder Reduce Bleeding?

L.A. McKeown

November 25, 2015

News Daily News

Tras Años de Análisis, Watchman está Listo para Salir a Escena

April 03, 2015

News Daily News

After Years of Scrutiny, Watchman Ready for Prime Time

April 03, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Todd Neale

December 11, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Jason Kahn

February 28, 2013

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

Advertisement

More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Does the Watchman LAA Occluder Reduce Bleeding?

Tras Años de Análisis, Watchman está Listo para Salir a Escena

After Years of Scrutiny, Watchman Ready for Prime Time

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content